A detailed history of Met Life Investment Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 176,006 shares of EXEL stock, worth $3.95 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
176,006
Holding current value
$3.95 Million
% of portfolio
0.03%

Shares

72 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$20.17 - $23.93 $3.55 Million - $4.21 Million
176,006 New
176,006 $4.18 Million
Q4 2023

Feb 14, 2024

SELL
$19.25 - $24.13 $142,334 - $178,417
-7,394 Reduced 3.84%
184,966 $4.44 Million
Q3 2023

May 09, 2024

SELL
$19.04 - $22.74 $329,963 - $394,084
-17,330 Reduced 8.26%
192,360 $4.2 Million
Q3 2023

Apr 29, 2024

SELL
$19.04 - $22.74 $238,856 - $285,273
-12,545 Reduced 6.12%
192,360 $4.2 Million
Q3 2023

Nov 14, 2023

SELL
$19.04 - $22.74 $238,856 - $285,273
-12,545 Reduced 6.12%
192,360 $4.2 Million
Q2 2023

Apr 29, 2024

BUY
$18.17 - $20.48 $3.72 Million - $4.2 Million
204,905 New
204,905 $3.92 Million
Q2 2023

Aug 10, 2023

SELL
$18.17 - $20.48 $86,943 - $97,996
-4,785 Reduced 2.28%
204,905 $3.92 Million
Q1 2023

May 09, 2024

BUY
$16.3 - $19.41 $3.42 Million - $4.07 Million
209,690 New
209,690 $4.07 Billion
Q1 2023

May 15, 2023

SELL
$16.3 - $19.41 $67,628 - $80,532
-4,149 Reduced 1.94%
209,690 $4.07 Million
Q4 2022

May 10, 2024

SELL
$14.96 - $17.39 $60,947 - $70,846
-4,074 Reduced 1.87%
213,839 $3.43 Million
Q4 2022

Jun 14, 2023

BUY
$14.96 - $17.39 $62,069 - $72,151
4,149 Added 1.98%
213,839 $3.43 Million
Q4 2022

Mar 22, 2023

SELL
$14.96 - $17.39 $60,947 - $70,846
-4,074 Reduced 1.87%
213,839 $3.43 Million
Q4 2022

Feb 15, 2023

SELL
$14.96 - $17.39 $60,947 - $70,846
-4,074 Reduced 1.87%
213,839 $3.43 Million
Q3 2022

May 10, 2024

SELL
$15.68 - $22.27 $27,737 - $39,395
-1,769 Reduced 0.81%
217,913 $3.42 Million
Q3 2022

Jun 14, 2023

BUY
$15.68 - $22.27 $128,936 - $183,126
8,223 Added 3.92%
217,913 $3.42 Million
Q3 2022

Mar 22, 2023

SELL
$15.68 - $22.27 $27,737 - $39,395
-1,769 Reduced 0.81%
217,913 $3.42 Million
Q3 2022

Nov 14, 2022

SELL
$15.68 - $22.27 $27,737 - $39,395
-1,769 Reduced 0.81%
217,913 $3.42 Million
Q2 2022

May 10, 2024

BUY
$17.44 - $23.16 $58,406 - $77,562
3,349 Added 1.55%
219,682 $4.57 Million
Q2 2022

Jun 20, 2023

BUY
$17.44 - $23.16 $174,260 - $231,414
9,992 Added 4.77%
219,682 $4.57 Million
Q2 2022

Mar 22, 2023

BUY
$17.44 - $23.16 $58,406 - $77,562
3,349 Added 1.55%
219,682 $4.57 Million
Q2 2022

Aug 11, 2022

BUY
$17.44 - $23.16 $58,406 - $77,562
3,349 Added 1.55%
219,682 $4.57 Million
Q1 2022

May 10, 2024

BUY
$17.03 - $22.67 $3.68 Million - $4.9 Million
216,333 New
216,333 $4.9 Million
Q1 2022

Jun 20, 2023

BUY
$17.03 - $22.67 $113,130 - $150,596
6,643 Added 3.17%
216,333 $4.9 Million
Q1 2022

Mar 22, 2023

BUY
$17.03 - $22.67 $1.07 Million - $1.43 Million
63,003 Added 41.09%
216,333 $4.9 Million
Q1 2022

May 12, 2022

BUY
$17.03 - $22.67 $1.07 Million - $1.43 Million
63,003 Added 41.09%
216,333 $4.9 Million
Q4 2021

May 17, 2024

BUY
$15.84 - $21.88 $31,331 - $43,278
1,978 Added 1.31%
153,330 $2.8 Million
Q4 2021

Jun 21, 2023

SELL
$15.84 - $21.88 $892,742 - $1.23 Million
-56,360 Reduced 26.88%
153,330 $2.8 Million
Q4 2021

Mar 22, 2023

BUY
$15.84 - $21.88 $17,297 - $23,892
1,092 Added 0.72%
153,330 $2.8 Million
Q4 2021

Feb 15, 2022

BUY
$15.84 - $21.88 $17,297 - $23,892
1,092 Added 0.72%
153,330 $2.8 Million
Q3 2021

May 17, 2024

SELL
$16.3 - $21.14 $85,412 - $110,773
-5,240 Reduced 3.35%
151,352 $3.2 Million
Q3 2021

Jun 21, 2023

SELL
$16.3 - $21.14 $950,909 - $1.23 Million
-58,338 Reduced 27.82%
151,352 $3.2 Million
Q3 2021

Mar 22, 2023

SELL
$16.3 - $21.14 $70,970 - $92,043
-4,354 Reduced 2.78%
152,238 $3.22 Million
Q3 2021

Nov 15, 2021

SELL
$16.3 - $21.14 $70,970 - $92,043
-4,354 Reduced 2.78%
152,238 $3.22 Million
Q2 2021

May 17, 2024

SELL
$17.95 - $25.56 $81,905 - $116,630
-4,563 Reduced 2.83%
156,592 $2.85 Million
Q2 2021

Jun 21, 2023

SELL
$17.95 - $25.56 $953,109 - $1.36 Million
-53,098 Reduced 25.32%
156,592 $2.85 Million
Q2 2021

Mar 22, 2023

SELL
$17.95 - $25.56 $153,077 - $217,975
-8,528 Reduced 5.16%
156,592 $2.85 Million
Q2 2021

Aug 16, 2021

SELL
$17.95 - $25.56 $153,077 - $217,975
-8,528 Reduced 5.16%
156,592 $2.85 Million
Q1 2021

May 17, 2024

SELL
$20.53 - $25.22 $304,891 - $374,542
-14,851 Reduced 8.44%
161,155 $3.64 Million
Q1 2021

Jun 26, 2023

SELL
$20.53 - $25.22 $996,423 - $1.22 Million
-48,535 Reduced 23.15%
161,155 $3.64 Billion
Q1 2021

Mar 22, 2023

SELL
$20.53 - $25.22 $95,464 - $117,273
-4,650 Reduced 2.74%
165,120 $3.73 Million
Q1 2021

May 14, 2021

SELL
$20.53 - $25.22 $95,464 - $117,273
-4,650 Reduced 2.74%
165,120 $3.73 Million
Q4 2020

May 24, 2024

SELL
$18.39 - $24.8 $131,341 - $177,121
-7,142 Reduced 4.04%
169,770 $3.41 Million
Q4 2020

Jun 22, 2023

SELL
$18.39 - $24.8 $734,128 - $990,016
-39,920 Reduced 19.04%
169,770 $3.41 Million
Q4 2020

Mar 22, 2023

SELL
$18.39 - $24.8 $131,341 - $177,121
-7,142 Reduced 4.04%
169,770 $3.41 Million
Q4 2020

Feb 16, 2021

SELL
$18.39 - $24.8 $131,341 - $177,121
-7,142 Reduced 4.04%
169,770 $3.41 Million
Q3 2020

May 24, 2024

SELL
$20.67 - $26.94 $107,442 - $140,034
-5,198 Reduced 2.85%
176,912 $4.33 Billion
Q3 2020

Jun 26, 2023

SELL
$20.67 - $26.94 $677,521 - $883,039
-32,778 Reduced 15.63%
176,912 $4.33 Million
Q3 2020

Mar 22, 2023

SELL
$20.67 - $26.94 $107,442 - $140,034
-5,198 Reduced 2.85%
176,912 $4.33 Million
Q3 2020

Nov 13, 2020

SELL
$20.67 - $26.94 $107,442 - $140,034
-5,198 Reduced 2.85%
176,912 $4.33 Million
Q2 2020

May 24, 2024

BUY
$16.46 - $27.42 $100,471 - $167,371
6,104 Added 3.47%
182,110 $4.32 Billion
Q2 2020

Jun 26, 2023

SELL
$16.46 - $27.42 $453,966 - $756,243
-27,580 Reduced 13.15%
182,110 $4.32 Million
Q2 2020

Mar 22, 2023

BUY
$16.46 - $27.42 $126,725 - $211,106
7,699 Added 4.41%
182,110 $4.32 Million
Q2 2020

Aug 14, 2020

BUY
$16.46 - $27.42 $126,725 - $211,106
7,699 Added 4.41%
182,110 $4.32 Million
Q1 2020

Jul 12, 2023

SELL
$14.46 - $21.8 $510,134 - $769,082
-35,279 Reduced 16.82%
174,411 $3 Million
Q4 2019

Jul 12, 2023

SELL
$15.15 - $18.89 $534,476 - $666,420
-35,279 Reduced 16.82%
174,411 $3.07 Million
Q4 2019

Mar 22, 2023

SELL
$15.15 - $18.89 $26,770 - $33,378
-1,767 Reduced 1.0%
174,411 $3.07 Million
Q4 2019

Feb 14, 2020

SELL
$15.15 - $18.89 $26,770 - $33,378
-1,767 Reduced 1.0%
174,411 $3.07 Million
Q3 2019

Jul 12, 2023

SELL
$17.68 - $22.65 $592,492 - $759,046
-33,512 Reduced 15.98%
176,178 $3.11 Million
Q3 2019

Mar 22, 2023

SELL
$17.68 - $22.65 $46,091 - $59,048
-2,607 Reduced 1.46%
176,178 $3.11 Million
Q3 2019

Nov 14, 2019

SELL
$17.68 - $22.65 $46,091 - $59,048
-2,607 Reduced 1.46%
176,178 $3.12 Million
Q2 2019

Jul 12, 2023

SELL
$18.93 - $24.75 $585,031 - $764,898
-30,905 Reduced 14.74%
178,785 $3.82 Million
Q2 2019

Mar 22, 2023

SELL
$18.93 - $24.75 $78,729 - $102,935
-4,159 Reduced 2.27%
178,785 $3.82 Million
Q2 2019

Aug 14, 2019

SELL
$18.93 - $24.75 $78,729 - $102,935
-4,159 Reduced 2.27%
178,785 $3.82 Million
Q1 2019

Jul 13, 2023

SELL
$19.6 - $24.76 $524,221 - $662,230
-26,746 Reduced 12.76%
182,944 $4.35 Million
Q1 2019

Mar 22, 2023

BUY
$19.6 - $24.76 $12,583 - $15,895
642 Added 0.35%
182,944 $4.35 Million
Q1 2019

May 15, 2019

BUY
$19.6 - $24.76 $12,583 - $15,895
642 Added 0.35%
182,944 $4.35 Million
Q4 2018

Jul 13, 2023

SELL
$13.65 - $21.8 $373,846 - $597,058
-27,388 Reduced 13.06%
182,302 $3.59 Million
Q4 2018

Mar 22, 2023

SELL
$13.65 - $21.8 $2,170 - $3,466
-159 Reduced 0.09%
182,302 $3.59 Million
Q4 2018

Feb 14, 2019

SELL
$13.65 - $21.8 $2,170 - $3,466
-159 Reduced 0.09%
182,302 $3.59 Million
Q3 2018

Jul 13, 2023

BUY
$15.87 - $22.4 $2.38 Million - $3.36 Million
150,022 Added 71.54%
359,712 $6.37 Million
Q3 2018

Mar 22, 2023

SELL
$15.87 - $22.4 $497,968 - $702,867
-31,378 Reduced 14.67%
182,461 $3.23 Million
Q3 2018

Nov 14, 2018

BUY
$15.87 - $22.4 $2.9 Million - $4.09 Million
182,461 New
182,461 $3.23 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $7.23B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.